Global Nucleic Acid-Based Multiplex Assays Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03245098

Publication Date:

March 22, 2024

Pages:

107

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Nucleic Acid-Based Multiplex Assays market size was valued at US$ 500.9 million in 2023. With growing demand in downstream market, the Nucleic Acid-Based Multiplex Assays is forecast to a readjusted size of US$ 818.1 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Nucleic Acid-Based Multiplex Assays market. Nucleic Acid-Based Multiplex Assays are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nucleic Acid-Based Multiplex Assays. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nucleic Acid-Based Multiplex Assays market.
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.听
A significant driver in the Nucleic Acid-Based Multiplex Assays market is the growing demand for rapid and comprehensive diagnostics, particularly in the fields of infectious diseases and genomics research. Multiplex assays enable the simultaneous detection of multiple nucleic acid targets in a single test, offering efficiency and cost-effectiveness. However, a notable challenge in this market is the need for assay standardization and data analysis. Ensuring that multiplex assays provide consistent and reliable results across different platforms and that data interpretation remains accessible while addressing potential challenges in assay design and optimization poses a significant challenge. Manufacturers and healthcare providers must collaborate to establish standards, streamline assay workflows, and develop user-friendly data analysis tools to maximize the potential of nucleic acid-based multiplex assays in various diagnostic and research applications.
Key Features:
The report on Nucleic Acid-Based Multiplex Assays market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Nucleic Acid-Based Multiplex Assays market. It may include historical data, market segmentation by Type (e.g., Reagents & Consumables, Instruments & Accessories), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nucleic Acid-Based Multiplex Assays market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nucleic Acid-Based Multiplex Assays market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Nucleic Acid-Based Multiplex Assays industry. This include advancements in Nucleic Acid-Based Multiplex Assays technology, Nucleic Acid-Based Multiplex Assays new entrants, Nucleic Acid-Based Multiplex Assays new investment, and other innovations that are shaping the future of Nucleic Acid-Based Multiplex Assays.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nucleic Acid-Based Multiplex Assays market. It includes factors influencing customer ' purchasing decisions, preferences for Nucleic Acid-Based Multiplex Assays product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nucleic Acid-Based Multiplex Assays market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nucleic Acid-Based Multiplex Assays market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nucleic Acid-Based Multiplex Assays market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nucleic Acid-Based Multiplex Assays industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nucleic Acid-Based Multiplex Assays market.
Market Segmentation:
Nucleic Acid-Based Multiplex Assays market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Reagents & Consumables
Instruments & Accessories
Software & Services
Segmentation by application
Companion Diagnostics
Research & Development
Clinical Diagnostics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid-Based Multiplex Assays Market Size 2019-2030
2.1.2 Nucleic Acid-Based Multiplex Assays Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nucleic Acid-Based Multiplex Assays Segment by Type
2.2.1 Reagents & Consumables
2.2.2 Instruments & Accessories
2.2.3 Software & Services
2.3 Nucleic Acid-Based Multiplex Assays Market Size by Type
2.3.1 Nucleic Acid-Based Multiplex Assays Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nucleic Acid-Based Multiplex Assays Market Size Market Share by Type (2019-2024)
2.4 Nucleic Acid-Based Multiplex Assays Segment by Application
2.4.1 Companion Diagnostics
2.4.2 Research & Development
2.4.3 Clinical Diagnostics
2.5 Nucleic Acid-Based Multiplex Assays Market Size by Application
2.5.1 Nucleic Acid-Based Multiplex Assays Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nucleic Acid-Based Multiplex Assays Market Size Market Share by Application (2019-2024)
3 Nucleic Acid-Based Multiplex Assays Market Size by Player
3.1 Nucleic Acid-Based Multiplex Assays Market Size Market Share by Players
3.1.1 Global Nucleic Acid-Based Multiplex Assays Revenue by Players (2019-2024)
3.1.2 Global Nucleic Acid-Based Multiplex Assays Revenue Market Share by Players (2019-2024)
3.2 Global Nucleic Acid-Based Multiplex Assays Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nucleic Acid-Based Multiplex Assays by Regions
4.1 Nucleic Acid-Based Multiplex Assays Market Size by Regions (2019-2024)
4.2 Americas Nucleic Acid-Based Multiplex Assays Market Size Growth (2019-2024)
4.3 APAC Nucleic Acid-Based Multiplex Assays Market Size Growth (2019-2024)
4.4 Europe Nucleic Acid-Based Multiplex Assays Market Size Growth (2019-2024)
4.5 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size Growth (2019-2024)
5 Americas
5.1 Americas Nucleic Acid-Based Multiplex Assays Market Size by Country (2019-2024)
5.2 Americas Nucleic Acid-Based Multiplex Assays Market Size by Type (2019-2024)
5.3 Americas Nucleic Acid-Based Multiplex Assays Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid-Based Multiplex Assays Market Size by Region (2019-2024)
6.2 APAC Nucleic Acid-Based Multiplex Assays Market Size by Type (2019-2024)
6.3 APAC Nucleic Acid-Based Multiplex Assays Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nucleic Acid-Based Multiplex Assays by Country (2019-2024)
7.2 Europe Nucleic Acid-Based Multiplex Assays Market Size by Type (2019-2024)
7.3 Europe Nucleic Acid-Based Multiplex Assays Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nucleic Acid-Based Multiplex Assays by Region (2019-2024)
8.2 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Type (2019-2024)
8.3 Middle East & Africa Nucleic Acid-Based Multiplex Assays Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nucleic Acid-Based Multiplex Assays Market Forecast
10.1 Global Nucleic Acid-Based Multiplex Assays Forecast by Regions (2025-2030)
10.1.1 Global Nucleic Acid-Based Multiplex Assays Forecast by Regions (2025-2030)
10.1.2 Americas Nucleic Acid-Based Multiplex Assays Forecast
10.1.3 APAC Nucleic Acid-Based Multiplex Assays Forecast
10.1.4 Europe Nucleic Acid-Based Multiplex Assays Forecast
10.1.5 Middle East & Africa Nucleic Acid-Based Multiplex Assays Forecast
10.2 Americas Nucleic Acid-Based Multiplex Assays Forecast by Country (2025-2030)
10.2.1 United States Nucleic Acid-Based Multiplex Assays Market Forecast
10.2.2 Canada Nucleic Acid-Based Multiplex Assays Market Forecast
10.2.3 Mexico Nucleic Acid-Based Multiplex Assays Market Forecast
10.2.4 Brazil Nucleic Acid-Based Multiplex Assays Market Forecast
10.3 APAC Nucleic Acid-Based Multiplex Assays Forecast by Region (2025-2030)
10.3.1 China Nucleic Acid-Based Multiplex Assays Market Forecast
10.3.2 Japan Nucleic Acid-Based Multiplex Assays Market Forecast
10.3.3 Korea Nucleic Acid-Based Multiplex Assays Market Forecast
10.3.4 Southeast Asia Nucleic Acid-Based Multiplex Assays Market Forecast
10.3.5 India Nucleic Acid-Based Multiplex Assays Market Forecast
10.3.6 Australia Nucleic Acid-Based Multiplex Assays Market Forecast
10.4 Europe Nucleic Acid-Based Multiplex Assays Forecast by Country (2025-2030)
10.4.1 Germany Nucleic Acid-Based Multiplex Assays Market Forecast
10.4.2 France Nucleic Acid-Based Multiplex Assays Market Forecast
10.4.3 UK Nucleic Acid-Based Multiplex Assays Market Forecast
10.4.4 Italy Nucleic Acid-Based Multiplex Assays Market Forecast
10.4.5 Russia Nucleic Acid-Based Multiplex Assays Market Forecast
10.5 Middle East & Africa Nucleic Acid-Based Multiplex Assays Forecast by Region (2025-2030)
10.5.1 Egypt Nucleic Acid-Based Multiplex Assays Market Forecast
10.5.2 South Africa Nucleic Acid-Based Multiplex Assays Market Forecast
10.5.3 Israel Nucleic Acid-Based Multiplex Assays Market Forecast
10.5.4 Turkey Nucleic Acid-Based Multiplex Assays Market Forecast
10.5.5 GCC Countries Nucleic Acid-Based Multiplex Assays Market Forecast
10.6 Global Nucleic Acid-Based Multiplex Assays Forecast by Type (2025-2030)
10.7 Global Nucleic Acid-Based Multiplex Assays Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Luminex
11.1.1 Luminex Company Information
11.1.2 Luminex Nucleic Acid-Based Multiplex Assays Product Offered
11.1.3 Luminex Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Luminex Main Business Overview
11.1.5 Luminex Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Product Offered
11.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Nucleic Acid-Based Multiplex Assays Product Offered
11.3.3 Illumina Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Bio-Rad Lab
11.4.1 Bio-Rad Lab Company Information
11.4.2 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Product Offered
11.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bio-Rad Lab Main Business Overview
11.4.5 Bio-Rad Lab Latest Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Information
11.5.2 QIAGEN Nucleic Acid-Based Multiplex Assays Product Offered
11.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 QIAGEN Main Business Overview
11.5.5 QIAGEN Latest Developments
11.6 BD
11.6.1 BD Company Information
11.6.2 BD Nucleic Acid-Based Multiplex Assays Product Offered
11.6.3 BD Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BD Main Business Overview
11.6.5 BD Latest Developments
11.7 Abcam
11.7.1 Abcam Company Information
11.7.2 Abcam Nucleic Acid-Based Multiplex Assays Product Offered
11.7.3 Abcam Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Abcam Main Business Overview
11.7.5 Abcam Latest Developments
11.8 Seegene
11.8.1 Seegene Company Information
11.8.2 Seegene Nucleic Acid-Based Multiplex Assays Product Offered
11.8.3 Seegene Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Seegene Main Business Overview
11.8.5 Seegene Latest Developments
11.9 Meso Scale Diagnostics
11.9.1 Meso Scale Diagnostics Company Information
11.9.2 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Product Offered
11.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Meso Scale Diagnostics Main Business Overview
11.9.5 Meso Scale Diagnostics Latest Developments
11.10 Randox Laboratories
11.10.1 Randox Laboratories Company Information
11.10.2 Randox Laboratories Nucleic Acid-Based Multiplex Assays Product Offered
11.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Randox Laboratories Main Business Overview
11.10.5 Randox Laboratories Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂